These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
302 related articles for article (PubMed ID: 32985124)
1. PLA2G16 is a mutant p53/KLF5 transcriptional target and promotes glycolysis of pancreatic cancer. Xia W; Bai H; Deng Y; Yang Y J Cell Mol Med; 2020 Nov; 24(21):12642-12655. PubMed ID: 32985124 [TBL] [Abstract][Full Text] [Related]
2. Pla2g16 phospholipase mediates gain-of-function activities of mutant p53. Xiong S; Tu H; Kollareddy M; Pant V; Li Q; Zhang Y; Jackson JG; Suh YA; Elizondo-Fraire AC; Yang P; Chau G; Tashakori M; Wasylishen AR; Ju Z; Solomon H; Rotter V; Liu B; El-Naggar AK; Donehower LA; Martinez LA; Lozano G Proc Natl Acad Sci U S A; 2014 Jul; 111(30):11145-50. PubMed ID: 25024203 [TBL] [Abstract][Full Text] [Related]
3. ARHGAP25 Inhibits Pancreatic Adenocarcinoma Growth by Suppressing Glycolysis via AKT/mTOR Pathway. Huang WK; Chen Y; Su H; Chen TY; Gao J; Liu Y; Yeh CN; Li S Int J Biol Sci; 2021; 17(7):1808-1820. PubMed ID: 33994864 [TBL] [Abstract][Full Text] [Related]
4. PLA2G16 promotes osteosarcoma metastasis and drug resistance via the MAPK pathway. Li L; Liang S; Wasylishen AR; Zhang Y; Yang X; Zhou B; Shan L; Han X; Mu T; Wang G; Xiong S Oncotarget; 2016 Apr; 7(14):18021-35. PubMed ID: 26933804 [TBL] [Abstract][Full Text] [Related]
5. DNMT1-maintained hypermethylation of Krüppel-like factor 5 involves in the progression of clear cell renal cell carcinoma. Fu RJ; He W; Wang XB; Li L; Zhao HB; Liu XY; Pang Z; Chen GQ; Huang L; Zhao KW Cell Death Dis; 2017 Jul; 8(7):e2952. PubMed ID: 28749461 [TBL] [Abstract][Full Text] [Related]
6. Suppression of inhibitor of differentiation 2, a target of mutant p53, is required for gain-of-function mutations. Yan W; Liu G; Scoumanne A; Chen X Cancer Res; 2008 Aug; 68(16):6789-96. PubMed ID: 18701504 [TBL] [Abstract][Full Text] [Related]
7. MiR-142-3p is downregulated in aggressive p53 mutant mouse models of pancreatic ductal adenocarcinoma by hypermethylation of its locus. Godfrey JD; Morton JP; Wilczynska A; Sansom OJ; Bushell MD Cell Death Dis; 2018 May; 9(6):644. PubMed ID: 29844410 [TBL] [Abstract][Full Text] [Related]
8. Krüppel-like factor 5 promotes breast cell proliferation partially through upregulating the transcription of fibroblast growth factor binding protein 1. Zheng HQ; Zhou Z; Huang J; Chaudhury L; Dong JT; Chen C Oncogene; 2009 Oct; 28(42):3702-13. PubMed ID: 19668233 [TBL] [Abstract][Full Text] [Related]
9. PLA2G16 Expression in Human Osteosarcoma Is Associated with Pulmonary Metastasis and Poor Prognosis. Liang S; Ren Z; Han X; Yang J; Shan L; Li L; Wang B; Zhang Q; Mu T; Chen K; Xiong S; Wang G PLoS One; 2015; 10(5):e0127236. PubMed ID: 25993412 [TBL] [Abstract][Full Text] [Related]
10. Krüppel-like factor 5 promotes lung tumorigenesis through upregulation of Sox4. Li Q; Dong Z; Zhou F; Cai X; Gao Y; Wang LW Cell Physiol Biochem; 2014; 33(1):1-10. PubMed ID: 24401325 [TBL] [Abstract][Full Text] [Related]
11. Screening of urine identifies PLA2G16 as a field defect methylation biomarker for prostate cancer detection. Jarrard WE; Schultz A; Etheridge T; Damodaran S; Allen GO; Jarrard D; Yang B PLoS One; 2019; 14(6):e0218950. PubMed ID: 31233548 [TBL] [Abstract][Full Text] [Related]
12. Up-regulation of Krüppel-like factor 5 in pancreatic cancer is promoted by interleukin-1beta signaling and hypoxia-inducible factor-1alpha. Mori A; Moser C; Lang SA; Hackl C; Gottfried E; Kreutz M; Schlitt HJ; Geissler EK; Stoeltzing O Mol Cancer Res; 2009 Aug; 7(8):1390-8. PubMed ID: 19671674 [TBL] [Abstract][Full Text] [Related]
13. Chromatin Looping Shapes KLF5-Dependent Transcriptional Programs in Human Epithelial Cancers. Liu Y; Guo B; Aguilera-Jimenez E; Chu VS; Zhou J; Wu Z; Francis JM; Yang X; Choi PS; Bailey SD; Zhang X Cancer Res; 2020 Dec; 80(24):5464-5477. PubMed ID: 33115806 [TBL] [Abstract][Full Text] [Related]
14. Therapeutic Targeting of the Warburg Effect in Pancreatic Cancer Relies on an Absence of p53 Function. Rajeshkumar NV; Dutta P; Yabuuchi S; de Wilde RF; Martinez GV; Le A; Kamphorst JJ; Rabinowitz JD; Jain SK; Hidalgo M; Dang CV; Gillies RJ; Maitra A Cancer Res; 2015 Aug; 75(16):3355-64. PubMed ID: 26113084 [TBL] [Abstract][Full Text] [Related]
15. TP63, SOX2, and KLF5 Establish a Core Regulatory Circuitry That Controls Epigenetic and Transcription Patterns in Esophageal Squamous Cell Carcinoma Cell Lines. Jiang YY; Jiang Y; Li CQ; Zhang Y; Dakle P; Kaur H; Deng JW; Lin RY; Han L; Xie JJ; Yan Y; Doan N; Zheng Y; Mayakonda A; Hazawa M; Xu L; Li Y; Aswad L; Jeitany M; Kanojia D; Guan XY; Said JW; Yang W; Fullwood MJ; Lin DC; Koeffler HP Gastroenterology; 2020 Oct; 159(4):1311-1327.e19. PubMed ID: 32619460 [TBL] [Abstract][Full Text] [Related]
16. PLAGL1 is associated with prognosis and cell proliferation in pancreatic adenocarcinoma. Liang X; Fu Z; Tang L; Zheng M; Chen D; Liu A; Shi L; Yang L; Shao C; Dong X BMC Gastroenterol; 2023 Jan; 23(1):2. PubMed ID: 36600208 [TBL] [Abstract][Full Text] [Related]
17. A novel KLF4/LDHA signaling pathway regulates aerobic glycolysis in and progression of pancreatic cancer. Shi M; Cui J; Du J; Wei D; Jia Z; Zhang J; Zhu Z; Gao Y; Xie K Clin Cancer Res; 2014 Aug; 20(16):4370-80. PubMed ID: 24947925 [TBL] [Abstract][Full Text] [Related]
18. C5a induces A549 cell proliferation of non-small cell lung cancer via GDF15 gene activation mediated by GCN5-dependent KLF5 acetylation. Zhao C; Li Y; Qiu W; He F; Zhang W; Zhao D; Zhang Z; Zhang E; Ma P; Liu Y; Ma L; Yang F; Wang Y; Shu Y Oncogene; 2018 Aug; 37(35):4821-4837. PubMed ID: 29773900 [TBL] [Abstract][Full Text] [Related]
19. AMP‑activated protein kinase family member 5 is an independent prognostic indicator of pancreatic adenocarcinoma: A study based on The Cancer Genome Atlas. Xu H; Mao J; Yang X; Chen F; Song Z; Fei J; Chen W; Zhong Z; Wang X Mol Med Rep; 2020 Nov; 22(5):4329-4339. PubMed ID: 33000197 [TBL] [Abstract][Full Text] [Related]
20. SLC45A4 promotes glycolysis and prevents AMPK/ULK1-induced autophagy in TP53 mutant pancreatic ductal adenocarcinoma. Chen W; Huang F; Huang J; Li Y; Peng J; Zhuang Y; Huang X; Lu L; Zhu Z; Zhang S J Gene Med; 2021 Sep; 23(9):e3364. PubMed ID: 34010493 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]